Download this Paper Open PDF in Browser

What Do Drug Monopolies Cost Consumers in Developing Countries?

11 Pages Posted: 24 Dec 2011  

Rebecca Hellerstein

Federal Reserve Bank of New York

Date Written: December 1, 2011

Abstract

This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Keywords: Intellectual property rights, international price discrimination, TRIPS agreement, pharmaceutical industry, markups

JEL Classification: D4, F13, L1, L65, O34

Suggested Citation

Hellerstein, Rebecca, What Do Drug Monopolies Cost Consumers in Developing Countries? (December 1, 2011). FRB of New York Staff Report No. 530. Available at SSRN: https://ssrn.com/abstract=1976372 or http://dx.doi.org/10.2139/ssrn.1976372

Rebecca Hellerstein (Contact Author)

Federal Reserve Bank of New York ( email )

33 Liberty Street
New York, NY 10045
United States

Paper statistics

Downloads
58
Rank
310,985
Abstract Views
389